Roth Capital Starts Cell Therapeutics (CTIC) at Buy
Tweet
Share
E-mailGet Alerts CTIC Hot Sheet
Price: $9.09 --0%
Rating Summary:
10 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 20 | New: 69
Rating Summary:
10 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 20 | New: 69
Join SI Premium – FREE
Roth Capital initiates coverage on Cell Therapeutics (NASDAQ: CTIC) with a Buy. PT $4.00.
For an analyst ratings summary and ratings history on Cell Therapeutics click here. For more ratings news on Cell Therapeutics click here.
Shares of Cell Therapeutics closed at $1.54 yesterday.
For an analyst ratings summary and ratings history on Cell Therapeutics click here. For more ratings news on Cell Therapeutics click here.
Shares of Cell Therapeutics closed at $1.54 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Capital Starts Tempus AI Inc (TEM) at Hold
- Freedom Capital Starts Heartflow Inc (HTFL) at Buy
- Wolfe Research Starts SLB (SLB) at Outperform, 'lowest risk option on a selective capital cycle'
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
